Small BusinessWockhardt advances on getting US FDA nod
Wockhardt has closed at Rs 181, higher by Rs 6 or 3.5%, on the BSE.
- Strides Arcolab soars on Pfizer deal - M&M slips on plans of aviation extention - Wockhardt gets tentative nod from US FDA - Novartis gains on plans of Alcon buy - Sugar stocks jump as prices touch record high - Tata Motors hits new 52-wk high on Dec sales nos
The scrip opened at Rs 180, which also happened to be the day"s low, and a high of Rs 186.
The counter has clocked volumes of 2.46 lakh shares compared to the two-week daily average traded volumes of 0.84 lakh shares.
------------------------------------------------------------------------------------------------(updated at 1040am)
Pharma major Wockhardt has advanced 4% on getting tentative nod from US FDA.
The scrip opened at Rs 180 and touched a high of Rs 186. The scrip is now trading at Rs 183, up 4% from its previous close. The counter has clocked volumes of 1.26 lakhs on the BSE as compared to the two-week daily average traded volumes of 0.84 lakh shares on the BSE.
The company has got the approval from the US drug regulator to market "Memantine HCl" tablets, used for the treatment of Alzheimer"s disease and dementia.